Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma - a LWP-EBMT study.

Bazarbachi A, Boumendil A, Finel H, Castagna L, Dominietto A, Blaise D, Diez-Martin JL, Tischer J, Gülbas Z, Wallet HL, Corral LL, Mohty M, Koc Y, Yakoub-Agha I, Schmid C, El Cheikh J, Arat M, Forcade E, Dreger P, Rocha V, García GG, Chalandon Y, Ferra C, Orvain C, Robinson S, Montoto S, Sureda A.

Br J Haematol. 2019 Sep 9. doi: 10.1111/bjh.16182. [Epub ahead of print]

PMID:
31498883
2.

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.

Skayneh H, Jishi B, Hleihel R, Hamieh M, Darwiche N, Bazarbachi A, El Sabban M, El Hajj H.

Genes (Basel). 2019 Aug 13;10(8). pii: E614. doi: 10.3390/genes10080614. Review.

3.

Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma.

Atoui A, El Labban M, Ghaoui N, El Darsa H, Cheikh J, Bazarbachi A.

Bone Marrow Transplant. 2019 Aug 12. doi: 10.1038/s41409-019-0635-9. [Epub ahead of print] No abstract available.

PMID:
31406225
4.

Allogeneic stem cell transplantation for acquired pure red cell aplasia.

Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party.

Am J Hematol. 2019 Aug 8. doi: 10.1002/ajh.25609. [Epub ahead of print] No abstract available.

PMID:
31396977
5.

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness.

Boileau M, Shirinian M, Gayden T, Harutyunyan AS, Chen CCL, Mikael LG, Duncan HM, Neumann AL, Arreba-Tutusaus P, De Jay N, Zeinieh M, Rossokhata K, Zhang Y, Nikbakht H, Mouawad C, Massoud R, Frey F, Nasr R, El Cheikh J, El Sabban M, Kleinman CL, Mahfouz R, Minden MD, Jabado N, Bazarbachi A, Eppert K.

Nat Commun. 2019 Jun 28;10(1):2891. doi: 10.1038/s41467-019-10705-z.

6.

Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.

Iqbal M, Reljic T, Klocksieben F, Sher T, Ayala E, Murthy H, Bazarbachi A, Kumar A, Kharfan-Dabaja MA.

Biol Blood Marrow Transplant. 2019 Aug;25(8):1695-1700. doi: 10.1016/j.bbmt.2019.05.027. Epub 2019 May 25.

PMID:
31132453
7.

Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update.

Battipaglia G, Massoud R, Ahmed SO, Legrand O, El Cheikh J, Youniss R, Aljurf M, Mohty M, Bazarbachi A.

Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):506-508. doi: 10.1016/j.clml.2019.04.004. Epub 2019 Apr 18.

PMID:
31122828
8.

Complete sequence of human T cell leukemia virus type 1 in ATLL patients from Northeast Iran, Mashhad revealed a prematurely terminated protease and an elongated pX open reading frame III.

Mirhosseini A, Mohareri M, Arab R, Rezaee SA, Shirdel A, Koshyar MM, Allahyari A, Bari A, Rahimi H, Mozaheb Z, Bazarbachi A, Boostani R, Mashkani B, Rafatpanah H.

Infect Genet Evol. 2019 Sep;73:460-469. doi: 10.1016/j.meegid.2019.05.012. Epub 2019 May 16.

PMID:
31102740
9.

Validation of a Drosophila model of wild type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: An effective platform for treatment screening.

Al Outa A, Abubaker D, Bazarbachi A, El Sabban M, Shirinian M, Nasr R.

Haematologica. 2019 May 17. pii: haematol.2019.219394. doi: 10.3324/haematol.2019.219394. [Epub ahead of print]

10.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Bone Marrow Transplant. 2019 May 15. doi: 10.1038/s41409-019-0451-2. [Epub ahead of print]

PMID:
31092900
11.

Antitumor efficacy of arsenic/interferon in preclinical models of chronic myeloid leukemia resistant to tyrosine kinase inhibitors.

El Eit R, Itani AR, Nassar F, Rasbieh N, Jabbour M, Santina A, Zaatari G, Mahon FX, Bazarbachi A, Nasr R.

Cancer. 2019 Aug 15;125(16):2818-2828. doi: 10.1002/cncr.32130. Epub 2019 Apr 29.

PMID:
31034603
12.

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.

Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, Rizzo D, Pasquini M, Hamadani M, Saber W, Hari P, Kharfan-Dabaja M, Majhail N, Gerges U, Hamidieh AA, Hussain F, Elhaddad A, Mahmoud HK, Tbakhi A, Othman TB, Hamladji RM, Bekadja MA, Ahmed P, Bazarbachi A, Adil S, Alkindi S, Ladeb S, Dennison D, Patel M, Lu P, Quessar AE, Okamoto S, Atsuta Y, Alhejazi A, Ayas MF, Ahmed SO, Novitzky N, Srivastava A, Seber A, Solh HE, Ghavamzadeh A, Confer D, Kodera Y, Hildegard G, Szer J, Horowitz MM, Niederwieser D.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30235-6. doi: 10.1016/j.bbmt.2019.04.012. [Epub ahead of print] Review.

PMID:
31002990
13.

Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party.

Bazarbachi A, Labopin M, Battipaglia G, Djabali A, Passweg J, Socié G, Forcade E, Blaise D, Chevallier P, Orvain C, Cornelissen JJ, Arcese W, Chantepie S, Hashaishi K, Cheikh JE, Medinger M, Esteve J, Nagler A, Mohty M.

Haematologica. 2019 Sep;104(9):e398-e401. doi: 10.3324/haematol.2018.211615. Epub 2019 Feb 21. No abstract available.

14.

Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis.

El-Cheikh J, Atoui A, Moukalled N, Ghaoui N, El Darsa H, Kanj SS, Bazarbachi A.

Med Mycol Case Rep. 2019 Jan 12;23:68-71. doi: 10.1016/j.mmcr.2019.01.001. eCollection 2019 Mar.

15.

Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.

Assaf N, El-Cheikh J, Bazarbachi A, Salem Z, Farra C, Chakhachiro Z, Nassif S, Zaatari G, Mahfouz R.

Mol Biol Rep. 2019 Apr;46(2):2003-2011. doi: 10.1007/s11033-019-04649-2. Epub 2019 Jan 30.

PMID:
30701458
16.

Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T.

J Clin Oncol. 2019 Mar 10;37(8):677-687. doi: 10.1200/JCO.18.00501. Epub 2019 Jan 18.

17.

Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK.

Hematol Oncol Stem Cell Ther. 2019 Jan 11. pii: S1658-3876(18)30122-5. doi: 10.1016/j.hemonc.2018.12.003. [Epub ahead of print] Review.

18.

Correction to: Mucormycosis in hospitalized patients at a tertiary care center in Lebanon: a case series.

Zein SE, El-Cheikh J, Zakhem AE, Ibrahim D, Bazarbachi A, Kanj SS.

Infection. 2019 Apr;47(2):335. doi: 10.1007/s15010-018-1259-5.

PMID:
30617837
19.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill J, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Biol Blood Marrow Transplant. 2019 Mar;25(3):e76-e85. doi: 10.1016/j.bbmt.2018.12.068. Epub 2018 Dec 18.

PMID:
30576834
20.

Haploidentical related donor allogeneic hematopoietic stem cell transplantation for patient aged older than 76 years with refractory acute myeloid leukemia.

El-Cheikh J, Salem R, Massoud R, Salem C, Ghaoui N, Kanj SS, Mahfouz R, Bazarbachi A.

Hematol Oncol Stem Cell Ther. 2018 Dec 9. pii: S1658-3876(18)30119-5. doi: 10.1016/j.hemonc.2018.11.005. [Epub ahead of print] No abstract available.

Supplemental Content

Loading ...
Support Center